We assessed the utility of adaptive WGS to call single-nucleotide polymorphisms (SNPs) and small insertions by examining pharmacogenomically relevant SNVs in TPMT, and FLT3 internal tandem duplication (FLT3-ITD)—a driving mutation in pediatric AML (Table S5). The gene discussed is TPMT; the disease is acute myeloid leukemia.